alexa Editor - Eleonore Frohlich | sample | 16248
ISSN: 2329-9053

Journal of Molecular Pharmaceutics & Organic Process Research
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Eleonore Frohlich

Eleonore Frohlich
Eleonore Frohlich
Director
Center for Medical Research
Medical University of Graz
Austria
Read Interview session with Eleonore Frohlich

Biography

Eleonore Fröhlich is Director of the Core Facility Imaging at the Center for Medical Research at the Medical University of Graz, Austria and professor at the University of Tübingen, Germany. She holds a Medical degree and a Diploma in Biochemistry from the Universities Tübingen and Heidelberg, Germany and specialized in Histology & Embryology and Anatomy. Her past research activities include studies on retina and retinal pigment epithelium, role of proteases in skin cancer, and differentiation therapy in thyroid cancer. Present research topics include biological and toxicological evaluation of nanoparticles and the development of physiologically relevant in-vitro models. Eleonore Fröhlich is Editorial Board Member of 6 journals and acts as reviewer for more than 70 journals and grant agencies.

Research Interest

Toxicology
Nanoparticles
Microscopy
In-vitro models

Certificate

Certificate

Global Speakers in the subject

Global Experts in the subject

Publications

Alternatives to Animal Procedures in Drug Development

Role of In-silico modeling in Drug Development for Inhalation Treatment

Eleonore Frohlich
Letter to Editor: J Mol Pharm Org Process Res 2016, 4:132
DOI: 10.4172/2329-9053.1000132
Shengqian Wu, Sharareh Salar-Behzadi and Eleonore Fröhlich E
Short Communication: J Mol Pharm Org Process Res 2013, 1:106
DOI: 10.4172/2329-9053.1000106
Top